Infectious Diseases 2015: The Antimicrobial Peptides Delivery Strategies Based on Nanotechnology to Treat Infectious Diseases
January 2019
in “
Research & Reviews: Journal of Pharmaceutics and Nanotechnology
”
Studysummary This review discusses polycystic ovary syndrome's metabolic and reproductive impacts, highlighting its insulin resistance and related complications, but reports no new research findings, underscoring the need for lifestyle modifications.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
In 2018, Groo Anne-Claire from the University of Angers conducted a study on the use of nanotechnology for the delivery of antimicrobial peptides (AMPs) to treat infectious diseases. The study was motivated by the growing resistance to traditional antibiotics and the potential of AMPs as new therapeutics. The research used Polymyxin B, an antimicrobial peptide, and lipid nanocapsules (LNCs) as a delivery method. The study found that Polymyxin B was efficiently encapsulated in LNCs and its antimicrobial activity remained intact. The study concluded that LNCs are an excellent candidate for delivering AMPs, suggesting that nanotechnology could improve the efficiency and stability of AMPs in clinical development.
